Canadian Tech Firm Secures Largest Contract to Date
Source: Streetwise Reports  (4/6/19)
The new client, in the U.S., is a state governmental agency. More >

Biotech Achieves Development Milestone for Blue Light Imaging System
Source: Streetwise Reports  (4/5/19)
The surgical imaging firm continues to advance its first medical device toward commercialization. More >

Canadian Life Sciences Firm Seeks Collaborative Cannabis Partner
Source: Streetwise Reports  (4/5/19)
This represents the company's expansion into another business area. More >

Innovative Healthcare Tech Firm to Acquire Two Vancouver Pharmacies
Source: Streetwise Reports  (4/3/19)
The transaction will allow the company to add a prescription fill and fulfillment component to its telemedicine app. More >

Biopharma Expects Data Readouts in Psoriasis, NASH in H2/19
Source: Streetwise Reports  (4/3/19)
Two recently launched clinical trials, and related conference calls, were reviewed in an H.C. Wainwright & Co. report. More >

CBD Firm Tallies Strong Q4/18 Performance, 2019 Outlook
Source: Streetwise Reports  (4/3/19)
A ROTH Capital Partners report reviewed the numbers for 2018 and explained why this Colorado-based company should perform well this year. More >

Cannabis Beverages, Edibles Company Receives Key Permit
Source: Streetwise Reports  (4/3/19)
This represents a major milestone for the firm on its path to commercializing its products. More >

Best-of-Breed Hemp/CBD Producers
Source: Fincom Investment Partners for Streetwise Reports  (4/2/19)
Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed." More >

Biopharma Hits Milestone in Starting Enrollment for NASH Clinical Trial
Source: Streetwise Reports  (3/30/19)
The company will discuss the trial when it hosts a conference call about this specific disease indication in April. More >

Firm Signs Paid Pilot Agreements to Test Telemedicine Platform in 5 States
Source: Streetwise Reports  (3/30/19)
With this development, the Canadian company further expands its U.S. footprint. More >

Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer
Source: Streetwise Reports  (3/30/19)
The "encouraging" data for this drug candidate as a monotherapy is the focus of an H.C. Wainwright & Co. report. More >

California Gold Entering High-CBD Content Hemp Seed Market in the U.S.
Source: Peter Epstein for Streetwise Reports  (3/28/19)
Peter Epstein of Epstein Research profiles a gold company that plans to grow hemp seed on its land. More >

Premier Health Group Adding Medical Cannabis Support Tool
Source: Streetwise Reports  (3/27/19)
This clinical decision support software integration is the first of its kind, according to the company. More >

San Diego Biopharma Features 'Strong and Balanced Pipeline'
Source: Streetwise Reports  (3/26/19)
An H.C. Wainwright & Co. report discussed what sets this company's asset apart from similar products. More >

Dosing Begins for California Biopharma's Proof-of-Concept Trial in Plaque Psoriasis
Source: Streetwise Reports  (3/25/19)
This U.S. study follows encouraging results from a Phase 1b trial in the same indication in Australia. More >

Biotech Stresses Need to Target Only Toxic Oligomer in Alzheimer's Therapies
Source: Streetwise Reports  (3/25/19)
The company cites the recent discontinuation of other firms' clinical programs as proof. More >

Now Cashed Up, Biopharma to Advance Cholesterol-Lowering Therapy
Source: Streetwise Reports  (3/23/19)
A ROTH Capital Partners report reviewed this New Jersey firm's plans for its lead asset. More >

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'
Source: Streetwise Reports  (3/22/19)
An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. More >

Rare Diseases Biotech Provides Opportunity
Source: Streetwise Reports  (3/21/19)
A ROTH Capital Partners report discussed why the stock price is at its current level and noted upcoming catalysts for the company. More >

Tech Firm to Offer Solution to Inefficient, Expensive Health Clinic Business Model
Source: Streetwise Reports  (3/20/19)
The company will roll out virtual, remote medical services to change how primary care practices are run. More >

Biopharma Expected to Bring 'Two First-in-Class Antibiotics to Market in 2019'
Source: Streetwise Reports  (3/19/19)
The likely timelines for approval and commercialization of each drug are discussed in an H.C. Wainwright report. More >

Cannabis Firm Announces Brand for Recreational Aficionados
Source: Streetwise Reports  (3/19/19)
This Canadian company intends to next launch a marketing campaign for the new product suite. More >

5 Small-Caps on Fund Manager Steve Palmer's Radar Screen
Source: Streetwise Reports  (3/19/19)
Steve Palmer, Founding Partner, President and Chief Investment Officer for AlphaNorth Asset Management, talks about a handful of companies in diverse industries that have his attention. More >

Antibody Therapeutics Developer to Present at March Alzheimer's/Parkinson's Conference
Source: Streetwise Reports  (3/19/19)
The biotech was selected to discuss its antibodies that selectively target toxic forms of alpha-synuclein. More >

Health Tech Firm Completes Enrollment for Female Sexual Function Trial
Source: Streetwise Reports  (3/15/19)
A Ladenburg Thalmann report reviewed the study design and purpose. More >